Patient experience of telemedicine for osteoporosis care during the COVID-19 pandemic

Clin Endocrinol (Oxf). 2023 Jan;98(1):134-135. doi: 10.1111/cen.14661. Epub 2021 Dec 21.

Authors

Alicia R Jones^{1

2}, Peter R Ebeling^{2

3}, Helena Teede^{1

2

4}, Frances Milat^{2

5}, Amanda J Vincent^{1

2}

Affiliations

¹ Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
² Department of Endocrinology, Monash Health, Melbourne, Australia.
³ Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia.
⁴ Monash Partner's Academic Health Science Centre, Victoria, Australia.
⁵ Hudson Institute of Medical Research, Melbourne, Australia.

PMID: 34914125
DOI: 10.1111/cen.14661

No abstract available

Keywords: COVID-19; osteoporosis; telemedicine.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

COVID-19*
Humans
Osteoporosis* / diagnosis
Osteoporosis* / therapy
Pandemics
Patient Outcome Assessment